The General Hospital Corporation, et al v. Esoterix Genetic Laboratories, LLC, et al
| QIAGEN MANCHESTER, LTD. and QIAGEN, INC. |
| DANA-FARBER CANCER INSTITUTE and GENERAL HOSPITAL CORP. |
| LABORATORY CORPORATION OF AMERICA HOLDINGS, a/k/a Laboratory Corporation of America and ESOTERIX GENETIC LABORATORIES, LLC |
| 20-2149 |
| December 5, 2020 |
| U.S. Court of Appeals, First Circuit |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 2, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| NOTICE of default and intent to dismiss issued directing Appellant/Cross-Appellee Esoterix Genetic Laboratories, LLC to file a brief or this case will be dismissed for lack of prosecution in accordance with 1st Cir. R. 45.0(a). Brief due 02/16/2021 . [20-2126, 20-2149] (GB) [Entered: 02/02/2021 07:04 AM] |
| JOINT APPENDIX filed by Appellant/Cross-Appellee Esoterix Genetic Laboratories, LLC in 20-2126, 20-2149. Certificate of service dated 02/01/2021. [20-2126, 20-2149] (AVN) [Entered: 02/01/2021 03:38 PM] |
| APPENDIX tendered by Appellant/Cross-Appellee Esoterix Genetic Laboratories, LLC in 20-2126, 20-2149. Certificate of service dated 02/01/2021. [20-2126, 20-2149] (RIS) [Entered: 02/01/2021 03:06 PM] |
| NOTICE of appearance on behalf of Appellant/Cross-Appellee Esoterix Genetic Laboratories, LLC and Appellee Laboratory Corporation of America Holdings in 20-2126, 20-2149 filed by Attorney Christopher R. Howe. Certificate of service dated 01/08/2021. [20-2126, 20-2149] (CRH) [Entered: 01/08/2021 01:49 PM] |
| NOTICE of appearance on behalf of Appellees/Cross-Appellants General Hospital Corp. and Dana-Farber Cancer Institute in 20-2149, 20-2126 filed by Attorney Douglas J. Nash. Certificate of service dated 01/07/2021. [20-2149, 20-2126] (DJN) [Entered: 01/07/2021 03:47 PM] |
| NOTICE issued. The following attorney has failed to register for an appellate ECF account and will no longer receive notice of court issued documents in this case: Douglas J. Nash for Dana-Farber Cancer Institute and General Hospital Corp.. [20-2149] (GB) [Entered: 01/06/2021 06:40 AM] |
| DISCLOSURE statement filed by Appellee/Cross-Appellant General Hospital Corp. in 20-2126, 20-2149. Certificate of service dated 12/22/2020. [20-2126, 20-2149] CLERK'S NOTE: Party selection was incomplete. Correction made by clerk's office. No further action required. (CMC) [Entered: 12/22/2020 10:18 AM] |
| DISCLOSURE statement filed by Appellee/Cross-Appellant Dana-Farber Cancer Institute in 20-2126, 20-2149. Certificate of service dated 12/22/2020. [20-2126, 20-2149] CLERK'S NOTE: Party selection was incomplete. Correction made by clerk's office. No further action required. (CMC) [Entered: 12/22/2020 10:16 AM] |
| CROSS-APPEAL briefing schedule set pursuant to F.R.A.P. 28.1. Brief and Appendix due 02/01/2021 for appellant Esoterix Genetic Laboratories, LLC. Please see the court's general order issued April 20, 2020, requiring the electronic filing of appendices. [20-2126, 20-2149] (GB) [Entered: 12/22/2020 08:44 AM] |
| NOTICE issued. After 01/05/2021, the following attorney will no longer receive notice of court issued documents in this case unless he registers for an appellate ECF account: Douglas J. Nash for Dana-Farber Cancer Institute and General Hospital Corp. [20-2149] (GB) [Entered: 12/22/2020 07:13 AM] |
| NOTICE of appearance on behalf of Appellees/Cross-Appellants General Hospital Corp. and Dana-Farber Cancer Institute filed by Attorney Carolyn M. Crowley. Certificate of service dated 12/21/2020. [20-2149] (CMC) [Entered: 12/21/2020 01:46 PM] |
| DOCKETING statement filed by Appellees/Cross-Appellants General Hospital Corp. and Dana-Farber Cancer Institute. Certificate of service dated 12/21/2020. [20-2149] (CMC) [Entered: 12/21/2020 01:48 PM] |
| TRANSCRIPT report/order form filed by Appellees/Cross-Appellants General Hospital Corp. and Dana-Farber Cancer Institute indicating all necessary transcripts have already been filed in district court. Certificate of service dated 12/21/2020. [20-2149] (CMC) [Entered: 12/21/2020 01:49 PM] |
ORDER directing the parties to proceed under F.R.A.P 28.1. The parties have filed cross-appeals in No. 1:18-cv-11360-IT (D. Mass.). Pursuant to Fed. R. App. P. 28.1, it is hereby ordered that defendant Esoterix Genetic Laboratories, LLC be deemed the appellant/cross-appellee (appellant) and that plaintiffs The General Hospital Corporation and Dana-Farber Cancer Institute, Inc. be deemed the appellees/cross-appellants (appellees). Defendant Laboratory Corporation of America Holdings is deemed a cross-appellee only. The parties are directed to use the above caption on all future filings related to these cases. A briefing schedule will be set once the record on appeal, including all necessary transcripts, is complete. The attached information sheet sets forth the filing requirements for briefs filed pursuant to Fed. R. App. P. 28.1. [20-2126, 20-2149] (GB) [Entered: 12/08/2020 09:27 AM]
|
| CIVIL CASE docketed. Notice of appeal (doc. #158) filed by Appellants Dana-Farber Cancer Institute and General Hospital Corp. Appearance form due, Docketing Statement and Transcript Report/Order form due 12/21/2020 . [20-2149] (GB) [Entered: 12/05/2020 01:13 PM] |
| CIVIL CASE docketed. Notice of appeal (doc. #158) filed by Appellants Dana-Farber Cancer Institute and General Hospital Corp. Appearance form due, Docketing Statement and Transcript Report/Order form due 12/21/2020 . [20-2149] (GB) [Entered: 12/05/2020 01:13 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
